186 related articles for article (PubMed ID: 25834425)
1. Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells.
Liu Y; Chen Q; Xu M; Guan G; Hu W; Liang Y; Zhao X; Qiao M; Chen D; Liu H
Int J Nanomedicine; 2015; 10():1855-67. PubMed ID: 25834425
[TBL] [Abstract][Full Text] [Related]
2. A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions.
Zhou J; Li M; Lim WQ; Luo Z; Phua SZF; Huo R; Li L; Li K; Dai L; Liu J; Cai K; Zhao Y
Theranostics; 2018; 8(2):518-532. PubMed ID: 29290824
[No Abstract] [Full Text] [Related]
3. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
Li X; Wu M; Pan L; Shi J
Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Cell-Specific Nuclear-Targeted Drug Delivery by Dual-Ligand-Modified Mesoporous Silica Nanoparticles.
Xiong L; Du X; Kleitz F; Qiao SZ
Small; 2015 Nov; 11(44):5919-26. PubMed ID: 26426251
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX.
Patel K; Sundara Raj B; Chen Y; Lou X
Colloids Surf B Biointerfaces; 2016 Apr; 140():213-222. PubMed ID: 26764104
[TBL] [Abstract][Full Text] [Related]
6. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J
J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004
[TBL] [Abstract][Full Text] [Related]
7. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
Liu CW; Lin WJ
J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
[TBL] [Abstract][Full Text] [Related]
8. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
[TBL] [Abstract][Full Text] [Related]
9. Programmed packaging of mesoporous silica nanocarriers for matrix metalloprotease 2-triggered tumor targeting and release.
Zou Z; He X; He D; Wang K; Qing Z; Yang X; Wen L; Xiong J; Li L; Cai L
Biomaterials; 2015 Jul; 58():35-45. PubMed ID: 25941780
[TBL] [Abstract][Full Text] [Related]
10. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.
Quan G; Pan X; Wang Z; Wu Q; Li G; Dian L; Chen B; Wu C
J Nanobiotechnology; 2015 Feb; 13():7. PubMed ID: 25643602
[TBL] [Abstract][Full Text] [Related]
11. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
[TBL] [Abstract][Full Text] [Related]
12. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
13. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
14. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
[TBL] [Abstract][Full Text] [Related]
15. N-Acetyl-D-glucosamine decorated polymeric nanoparticles for targeted delivery of doxorubicin: Synthesis, characterization and in vitro evaluation.
Tian B; Ding Y; Han J; Zhang J; Han Y; Han J
Colloids Surf B Biointerfaces; 2015 Jun; 130():246-54. PubMed ID: 25921641
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
[TBL] [Abstract][Full Text] [Related]
17. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
18. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
[TBL] [Abstract][Full Text] [Related]
19. Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin.
Kim S; Diab R; Joubert O; Canilho N; Pasc A
Colloids Surf B Biointerfaces; 2016 Apr; 140():161-168. PubMed ID: 26752213
[TBL] [Abstract][Full Text] [Related]
20. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]